Actavis became the owner of Norgesplaster in December 2005, following the acquisition of the generics division of Alpharma. Actavis’ focus remains on its core business, generic pharmaceuticals. Actavis will continue to operate a sales and marketing office in Oslo for pharmaceutical products.
Norgesplaster is Norway’s supplier of plasters and medical grade anchored products. Actavis and Norgesplaster AS will work together to ensure that there will be no disruption in supply or services. Current employees will continue to be employed by Norgesplaster.
The transaction was closed on 29 January 2010, but will have financial effect from 1 January 2010. The financial details of the transaction were not disclosed.